The evaluation of low-density lipoprotein cholesterol goals achieved in patients with established cardiovascular disease and/or hyperlipidaemia receiving lipid-lowering therapy: the South African Not At Goal study (SA-NAG)

AIM: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide. Dyslipidaemia is a major risk factor that leads to the clinical sequelae of CVD. As a result, it has become essential for South Africa to update its guidelines for the management of dyslipidaemia, and the So...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramjeeth, Akash, Butkow, Neil, Raal, Frederick, Maholwana-Mokgatlhe, Mandisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2008
Materias:
Cardiovascular Topics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975218/
https://www.ncbi.nlm.nih.gov/pubmed/18516354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3975218/
https://www.ncbi.nlm.nih.gov/pubmed/18516354

Ejemplares similares